EPZ011989 |
Inhibitor of EZH2, EZH1
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| EZH2 |
|
|
| EZH1 |
|
|
Inhibitor
100-600 nM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
15-fold selective for EZH2 > EZH1 in protein substrate methylation assay. 3000-fold selective for EZ ...
Selectivity Assessment Description:
15-fold selective for EZH2 > EZH1 in protein substrate methylation assay. 3000-fold selective for EZ ...
Potency Cellular
In Vitro
EZH2
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acsmedchemlett.5b00037
EZH1
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? No
DOI Reference: 10.1021/acsmedchemlett.5b00037
In Vivo Validations
Rat, Mouse
Dose: 30 mg/kg - 300 mg/kg (R), 125 - 1000 mg/kg (M)
Route of delivery:
Oral
Plasma half life:
3.7 - 4.7 h (R)
Organ of interest (O):
bone marrow, KARPAS-422 DLBCL tumor cell xenograft
Target engagement assay:
Indirect, protein substrate methylation in bone marrow and in tumor (xenograft).
DOI Reference: 10.1021/acsmedchemlett.5b00037
Chemical Information
| Molecular Formula | C35H51N5O4 |
| SMILEs | CCN(c1cc(C#CCN2CCOCC2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)[C@H]1CC[C@H](N(C)CCOC)CC1 |
| InChI | InChI=1S/C35H51N5O4/c1-7-40(30-12-10-29(11-13-30)38(5)15-18-43-6)33-23-28(9-8-14-39-16-19-44-20-17-39)22-31(27(33)4)34(41)36-24-32-25(2)21-26(3)37-35(32)42/h21-23,29-30H,7,10-20,24H2,1-6H3,(H,36,41)(H,37,42)/t29-,30- |
| Molecular weight | 605.39 Da |
| AlogP | 3.62956 |
| HBond acceptors | 9 |
| HBond donors | 2 |
| Atoms | 95 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.